Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBW 2992; Drug: Investigator´s choice of chemotherapy
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: linagliptin; Drug: placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Venous Thromboembolism
Intervention: Drug: dabigatran etexilate
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Head and Neck Cancer
Interventions: Drug: cetuximab; Drug: Cisplatin; Drug: Carboplatin; Drug: 5-fluorouracil
Sponsor: Eli Lilly and Company
Not yet recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo; Drug: Tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: Pramipexole Dihydrochloride; Drug: Pramipexole Dihydrochloride
Sponsor: Teva Pharmaceuticals USA
Completed - verified February 2010
Condition: Healthy
Interventions: Drug: Pramipexole Dihydrochloride; Drug: Pramipexole Dihydrochloride
Sponsor: Teva Pharmaceuticals USA
Completed - verified February 2010
Conditions: Non-small Cell Lung Cancer; EGFR Mutations
Intervention: Drug: BIBW 2992
Sponsors: Massachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Boehringer Ingelheim Pharmaceuticals
Not yet recruiting - verified February 2010